Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wushe Zhiyang Pill for eczema with blood deficiency and wind-dryness syndrome
ChiCTR2400085887Phase 4Recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Jun 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of wushe zhiyang wan in atopic dermatitis (AD) (2 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoint: Change in Eczema Area and Severity Index. Started Jun 2024; status: recruiting.
02
Drugs
wushe zhiyang wan
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on ChiCTR2400085887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085887.